Here's Your Shot to Score Big

Some of the best investment advice I've ever heard came from "The Great One."

But I don't mean Peter Lynch, Benjamin Graham, or even Warren Buffett. (Though as you're about to see, Buffett is a big fan of The Great One, too.) And I definitely don't mean Jim Cramer.

You've probably heard The Great One's name dozens of times, but you may not know just how wise he is. Nonetheless, he's said some very smart things. For instance ...

"You miss 100% of the shots you never take"
That's but one of the many pearls of wisdom The Great One has dropped over the years. And while it might seem obvious, or even trite, it's a truth we often take for granted.

Just think of the person you never asked to the dance, or the job you never applied for, or the novel you never finished ... or the stock you never purchased.

It happens to all of us. We get nervous, or doubtful, or busy, or ... you name it. And that might end up costing us the person of our dreams, or the job we've always wanted, or our only shot at fame. But in the case of investing, it will definitely cost us a fortune.

Back in 2007, two stocks sat on my watch list for a full 365 days:

Stock

Gain in 2007

Market Cap Today

Google

50%

$170 billion

Chipotle

158%

$3.1 billion

Apple

134%

$181 billion

A $32,100 mistake
Should I have bought them? Perhaps. But by not investing in them, I wound up making a grand total of ... nothing. Nada. Zip. Zilch.

That's a bitter pill to swallow, especially considering that if I'd invested five grand in each company at the beginning of 2007, I would have been sitting on $32,100 one year later.

I guess that's not as bad as all the people who boasted about how they were going to buy Goldman Sachs (NYSE: GS  ) , Starbucks (Nasdaq: SBUX  ) , or Las Vegas Sands (NYSE: LVS  ) last March and then didn't. But it does go to show you that if you want to score, you've got to take a shot.

And if we want to score really, really big ...
In that case, we have to follow The Great One's most famous piece of advice: "Skate to where the puck is going, not to where it's been."

You may already know that The Great One is hockey legend Wayne Gretzky. If not, all you need to know is that Gretzky was arguably the greatest player ever to take the ice.

What made him The Great One? Quite simply, he was always one step ahead of everyone else -- not because of his speed, but because of his anticipation. While everyone else skated to where the puck had just been, Gretzky always skated to where it was going next.

That's the key to great investing, too
And apparently, I'm not the only one who thinks so. In an op-ed piece he penned for The New York Times, Warren Buffett used this same quote to make the point that investors who keep their cash on the sidelines when market sentiment is negative are missing out on a potentially huge opportunity.

While I couldn't agree more with Mr. Buffett, I think this quote has an even more meaningful connection to small-cap investing. If you look at the tables below, you'll start to notice an interesting correlation between market cap and percentage gain: The smaller the business, the greater the returns. While this won't always be the case, this data is a quick and dirty way of showing that the best performers do indeed start small.

That's also how you can skate to where the puck is going next.

Bigger isn't better, but size does matter
For proof, just have a look at the top five best-performing stocks of the past 52 weeks with market caps greater than $5 billion:

Stock

Market Cap

52-Week Gain

Teck Resources

$20 billion

771%

Mechel OAO (ADR) (NYSE: MTL  )

$8.6 billion

692%

Seagate Technology (Nasdaq: STX  )

$8.4 billion

470%

Genworth Financial

$6.8 billion

449%

XL Capital

$5.7 billion

448%

Data provided by Google Finance.

Now compare that with the top five best-performing stocks of the past 52 weeks with market caps less than $5 billion:

Stock

Market Cap

52-Week Gain

Diedrich Coffee

$198 million

7,587%

Orient Paper

$139 million

3,134%

Select Comfort

$301 million

2,164%

Dollar Thrifty Automotive Group (NYSE: DTG  )

$539 million

2,001%

Cell Therapeutics (Nasdaq: CTIC  )

$626 million

1,703%

Data provided by Google Finance.

So, here's how you can score big in 2009 and beyond ...
First off, keep Buffett's advice in mind. Second, keep The Great One's advice in mind. Finally, take a page out of my colleague Tim Hanson's book, and make sure to dedicate at least a portion of your time to researching stocks that are obscure, ignored, and small.

These three traits have characterized some of the best-performing stocks of the past decade. More importantly, they will characterize some of the most lucrative stocks of the next 10 years.

In fact, we started our Motley Fool Hidden Gems service precisely to uncover businesses with these three traits. Since day one, our team members have dedicated themselves to discovering where the puck is going next.

And thanks to continuing market uncertainty, many of today's most promising small-cap stocks are still selling at bargain-basement discounts. So, if ever there were a perfect time to take your shot and score big, this is it.

Need a little help uncovering great small-cap stocks?
Great! You can get all of Hidden Gems' top small-cap research and recommendations -- including our top two picks for new money -- absolutely free by taking a 30-day guest pass.

You'll also be able to follow along as the Hidden Gems team invests $250,000 of The Motley Fool's own money in a best-of-the-best small-cap portfolio (so far, 11 of their 16 open positions are in the green, and five are already up more than 40%).

This offer is completely risk-free, with no obligation to subscribe. To get started, simply click here.

This article was first published Jan. 25, 2008. It has been updated.

Austin Edwards finally did buy shares of Google, Apple, and Chipotle in 2008. Chipotle Mexican Grill is a Motley Fool Hidden Gems recommendation. Chipotle Mexican Grill and Google are Rule Breakers picks. Apple and Starbucks are Stock Advisor recommendations. The Fool owns shares of Chipotle. The Fool's disclosure policy is the coolest game on Earth.


Read/Post Comments (1) | Recommend This Article (27)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 30, 2010, at 5:44 PM, sammywallstreet wrote:

    I believe corgenix medical corporation conx.ob is one of those small companies that can become big.

    They sell over 40 diagnostic products worldwide and have recently signed exclusive rights to manufacture bg medicine's potentially blockbuster heart failure test galectin-3. BG medicine will do an $85 million dollar IPO in order to market and lauch galectin-3 kit in eurpoe and the USA.

    Corgenis also has a strong pipeline that includes a test to measure liver fibrosis thus reducing the need for liver biopsies called hyaluronic acid kit.

    Management has forecasted record revenues for fiscal 2010.

Add your comment.

DocumentId: 1098625, ~/Articles/ArticleHandler.aspx, 7/22/2014 3:35:43 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement